Bioassay Bioinformatics DNA Scientist 
Drug Discovery World
NOVEMBER 9, 2023
Klaus Wagenbauer, PhD, Founder & CEO, Plectonic, on: ‘Programmable DNA-origami-based T cell engagers: PTE’. Gail Calvert, Field Application Scientist, Sartorius UK, on: ‘Leveraging integrated and advanced technologies for successful cell line development’.
Drug Discovery World
NOVEMBER 30, 2023
It was by Nicholas Field, Principal Scientist, Purification Development, Lonza, titled: ‘Tailored CMC solutions to overcome the challenges in bispecific, Fab and Fc-fusion protein development programs’. This presentation covered three primary drivers for a protein expression model: speed, cost and sustainability. “It
Expert insights. Personalized for you.
52 
Let's personalize your content